Skip to main content
. 2019 Feb 19;17(4):4024–4033. doi: 10.3892/ol.2019.10050

Figure 4.

Figure 4.

Cytotoxicity of nanoparticles examined in prostate cancer cells using the Cell Counting Kit-8 assay. Cell viability in (A) DU145 CD44+ cells, (B) DU145 CD44 cells, (C) 22RV1 CD44+ cells and (D) 22RV1 CD44 cells. Data are presented as the mean ± standard deviation (n=3). SM-LPN-CD44, salinomycin-encapsulated lipid-poly(lactide-co-glycolide acid) nanoparticles linked with CD44 antibodies; SM-LPN, salinomycin-encapsulated lipid-poly(lactide-co-glycolide acid) nanoparticles; LPN-CD44, blank lipid-poly(lactide-co-glycolide acid) nanoparticles linked with CD44 antibodies; CD, cluster of differentiation.